Louis Grandjean - Concepedia

Author

Louis Grandjean

London School of Hygiene & Tropical Medicine ORCID

Also Known As

Ana Luíza Gibertoni Cruz, Grandjean L., Grandjean, Louis, Katherine Fielding, L GRANDJEAN, L Grandjean, L. Grandjean, Louis Grandjean, Suzanne Anderson

134

Publications

6.1K

Citations

H-Index

Concepts

All Affiliations

London School of Hygiene & Tropical Medicine Universidad Peruana Cayetano Heredia University College London Imperial College London Johns Hopkins University

About

Louis Grandjean is an author at London School of Hygiene & Tropical Medicine specializing in medicine, clinical microbiology, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	2.1K
2	Health Sciences	6	6	571
3	Public Health	2	2	258
4	Engineering	1	1	11
5	Allergy	1	1	44

Louis Grandjean

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis Francesc Coll, Jody Phelan, Grant Hill-Cawthorne, Nature Genetics Pulmonary TuberculosisAntimicrobial Resistance GeneHealth SciencesTuberculosis PreventionTuberculosis	2018	421
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis Paolo Miotto, Claudio U. Köser, Philip W. Fowler, The Lancet Microbe	2022	282
6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study Justin Penner, Omar Abdel‐Mannan, Karlie Grant, The Lancet Child & Adolescent Health Family MedicineRetrospective Cohort StudyPrimary CarePediatric Epidemiology6-Month Multidisciplinary Follow-up	2021	203
Global expansion of <i>Mycobacterium tuberculosis</i> lineage 4 shaped by colonial migration and local adaptation Ola Brynildsrud, Caitlin S. Pepperell, Philip Noël Suffys, Science Advances	2018	170
‘The long tail of Covid-19’ - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients Ivan Doykov, Jenny Hällqvist, Kimberly Gilmour, F1000Research	2021	141
‘The long tail of Covid-19’ - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients Ivan Doykov, Jenny Hällqvist, Kimberly Gilmour, F1000Research ImmunodeficienciesHumoral ResponseImmunologyProlonged Inflammatory ResponseCovid-19 Epidemiology	2020	140

Page 1